MMSI vs VNDA: fair value comparison
Merit Medical Systems, Inc. and Vanda Pharmaceuticals Inc. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, MMSI currently sits closer to the top of our discount ranking. MMSI carries the stronger quality grade.
| MMSI | VNDA | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $85.53 | $5.23 |
| 12-month range | $62.01–$90.68 | $4.47–$8.25 |
| Sector rank | #33 of 113 Healthcare | #36 of 113 Healthcare |
| Quality grade | A | D |
| Momentum grade | A | — |
| Leverage | Moderate | Low |
| Margin trend | Expanding | — |
| Revenue growth | Strong | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Mixed |
| DCF cross-check | Overvalued | — |
| 52-week position | The top quarter | The bottom quarter |
Full single-stock breakdowns: MMSI fair value analysis · VNDA fair value analysis